Close search

Major Depression Disorder

View course details

MDD Augmentation Strategies

Atypical Antipsychotics

Lithium

Thyroid Hormones

L-Methylfolate

Lamotrigine

Stimulants

Buspirone

Pramipexole

S-Adenosyl Methionine (SAMe)

Creatine

Low Dose Naltrexone

Flow FL-100 (tDCS)

Evidence Based Treatment Guidelines

Update On Nonpsychotic Unipolar Depression Management

Comparing Guidelines for MDD Treatment: Pharmacotherapy vs Psychotherapy

Florida Best Practice Guidelines (2017- 2018)

Florida Best Practice Guidelines (2017- 2018): MDD with Mixed Features

Florida Best Practice Guidelines (2017- 2018): MDD with Psychosis

MDD PsychoPharamcology

Auveity: new Antidepressant for MDD

Gepirone (Exxua): New Antidepressant FDA Approved for MDD

Spravato: First Monotherapy FDA Approved for Treatment-Resistant MDD

Rejoyn: FDA Cleared First Prescription Digital Therapeutic for MDD

Trazodone Once-A-Day for MDD

Transdermal Selegiline for MDD

Sertraline’s Differential Timeline: A Symptom-Network Analysis for Clinicians

Ketamine Role in Psychiatry & Risk of Psychosis

How Long to Continue Antidepressants for MDD Treatment?

Medications vs Psychotherapy for MDD: Guidelines Comparison.

Antidepressants Discontinuation Syndrome Vs Depression Relapse

Psychotropic Medication of choice to Improve Cognition in MDD

Sleep-Wake Cycle & Antidepressants

Comparing Antidepressants

SSRIs vs SSRIs (Part-1)

SSRIs vs SSRIs (Part-2)

Serotonin Modulators: Trazodone vs Nefazodone

Serotonin Modulators: Vortioxetine vs Vilazodone

Comparing Long ActingAntidepressants Formulations

Comparing Antidepressants: Which one is better?

Grief

Grief versus Major Depressive Episode

Persistent Complex Bereavement Disorder Versus Prolonged Grief Disorder

What Questions to Ask? Grief Assessment Questionnaire.

Book: Life After Loss

Post Stroke Depression

Pathophysiology & Risk Factors

Treatment of Post Stroke Depression

Prevention of Post Stroke Depression

Back to Basics

Serotonin: Basics and Beyond

Mechanism of Action: Antidepressants (Part-1)

Mechanism of Action: Antidepressants (Part-2)

Suicide Risk Assessment

Course Information

Categories:

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .